mdl 72527 and Retinal Diseases

mdl 72527 has been researched along with Retinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caldwell, RB; Caldwell, RW; Lucas, R; Narayanan, SP; Patel, C; Shosha, E; Xing, J; Xu, Z	1

Other Studies

1 other study(ies) available for mdl 72527 and Retinal Diseases

Article	Year
Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy. Biochimica et biophysica acta, 2016, Volume: 1862, Issue:9 Topics: Animals; Cell Death; Cell Differentiation; Cells, Cultured; Culture Media, Conditioned; Disease Models, Animal; Enzyme Inhibitors; Female; Inflammation; Ischemia; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Putrescine; Rats; Retinal Diseases; Retinal Vessels	2016

Article

Year

Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy.

Biochimica et biophysica acta, 2016, Volume: 1862, Issue:9

Topics: Animals; Cell Death; Cell Differentiation; Cells, Cultured; Culture Media, Conditioned; Disease Models, Animal; Enzyme Inhibitors; Female; Inflammation; Ischemia; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Putrescine; Rats; Retinal Diseases; Retinal Vessels

2016